Once‐daily initiation of basal insulin as add‐on to metformin: a 26‐week, randomized, treat‐to‐target trial comparing insulin detemir with insulin glargine in patients …

L Meneghini, J Kesavadev, M Demissie… - Diabetes, obesity …, 2013 - Wiley Online Library
Aims This study assessed the efficacy and safety of once‐daily insulin initiation using insulin
detemir (detemir) or insulin glargine (glargine) added to existing metformin in type 2 …

Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel

AG Tabak, P Kempler, C Guja, R Eldor, M Haluzik… - Diabetes Therapy, 2024 - Springer
Despite the availability of various antihyperglycaemic therapies and comprehensive
guidelines, glycaemic control in diabetes management has not improved significantly during …

iGlarLixi versus basal plus Rapid‐Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real‐World study

RJ McCrimmon, AYY Cheng, G Galstyan… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim For people with suboptimally controlled type 2 diabetes (T2D) on basal insulin (BI),
guidelines recommend several treatment advancement options. This study compared the …

[HTML][HTML] Predicting real-world hypoglycemia risk in American adults with type 1 or 2 diabetes mellitus prescribed insulin and/or secretagogues: protocol for a …

A Ratzki-Leewing, BL Ryan, G Zou… - JMIR Research …, 2022 - researchprotocols.org
Background Hypoglycemia prognostic models contingent on prospective, self-reported
survey data offer a powerful avenue for determining real-world event susceptibility and …

Basal insulin analogues in type 1 diabetes–Does one size fit all? Lessons from the HypoDeg trial based on single-patient outcomes

S Hjejle, RM Agesen, B Thorsteinsson… - Heliyon, 2024 - cell.com
Abstract Aims In the HypoDeg trial, a randomised crossover trial in people with type 1
diabetes prone to nocturnal severe hypoglycaemia, treatment with insulin degludec (IDeg) …

Estimation of HbA1c and Impact of Continuous Glucose Monitoring in Hypoglycemic States

BK Mishra, A Raghav, GB Jeong, M Jain… - Glucose and Insulin …, 2024 - books.google.com
Glycosylated hemoglobin (HbA1c) is formed when glucose combines with hemoglobin
present in red blood cells making it glycated. Hypoglycemia is presented by less sugar …

[PDF][PDF] Design and Psychometrics of Diabetes Knowledge Questionnaire

A Mehrabbeik, R Azizi, M Rahmanian… - Journal of Medical …, 2022 - brieflands.com
Background: Due to the important role played by knowledge in controlling and managing
diabetes in most educational interventions, the assessment of the individuals' levels of …

[HTML][HTML] The Clinical Impact of Switching Basal Insulin to Insulin Degludec in Patients With Diabetes in Saudi Arabia: A Retrospective One-Group Pretest-Posttest …

A Althagafi, M Alshibani, SO Alshehri, A Barahim… - Cureus, 2022 - ncbi.nlm.nih.gov
Background: Diabetes is a health problem that has an enormous and intolerable public
health burden on the individual, family, and community. Diabetes affects nearly one-fifth of …

The Choice of Insulin Type and Regimen for Adolescents with Type 1 Diabetes during Ramadan Fasting: A Continuing Debate

R Hassan-Beck, A Deeb - Journal of Diabetes and Endocrine …, 2022 - thieme-connect.com
The intertwined complexity of type 1 diabetes (T1D) and the amplification of its associated
symptoms during Ramadan fasting inevitably imposes a challenge in the appropriate …

Hypoglykämien bei Diabetes mellitus: häufig und gefährlich

A Holstein, DJF Holstein - Diabetes aktuell, 2019 - thieme-connect.com
Schwere Hypoglykämien führen häufig zu Verletzungen und sind mit einer mehr als 2-fach
erhöhten kardiovaskulären Mortalität und Morbidität assoziiert. Hauptrisikofaktoren für …